Contraceptive Technology Update – July 1, 2005
July 1, 2005
View Archives Issues
-
What will it take for microbicides to go from research to reality?
The need for female-controlled protection against HIV and sexually transmitted diseases (STDs) has never been greater. While early in the epidemic, HIV infection and AIDS were diagnosed for relatively few women, the HIV/AIDS epidemic now represents a growing and persistent health threat to women in the United States as well as throughout the world. -
Does contraception affect HIV treatment?
Is your family planning facility seeing more women who are HIV-positive? Statistics point to a yes. In 2003, women accounted for 27% of the estimated 32,048 diagnoses of HIV infection in the United States, according to statistics from the Atlanta-based Divisions of HIV/AIDS Prevention of the Centers for Disease Control and Prevention (CDC). -
Research moves HPV vaccines within view
When discussing sexually transmitted diseases (STDs) with your patients, what do you tell them about human papillomavirus (HPV)? Exposure to HPV can have significant health implications, particularly for women. Some strains of the virus, including HPV-16 and HPV-18, can trigger cancers of the cervix. -
Sole U.S. distributor of cap closes business
The options in barrier contraceptives for American women have been reduced as the sole U.S. company distributing the Prentif Cavity-Rim Cervical Cap has announced its dissolution and the device is no longer available in the United States. -
Research hones in on EC mechanism of action
The young woman in your examination room has questions about how emergency contraception pills (ECPs) works. How do you explain the methods mechanism of action? -
Touchscreen technology — Coming to your clinic?
How do you broaden access to family planning services? Some family planning agencies are looking to touchscreen technology to get information front and center to those who may need their services. -
Corrections